Collaboration Deals in Pharmaceuticals 2020-2026

Key Benefits

✔ Save Significant Research Time
Access a consolidated database of collaboration deals instead of searching multiple databases, press releases, and regulatory filings.

✔ Benchmark Collaboration Deal Structures
Understand how companies structure collaborative partnerships, including development roles, financial arrangements, and commercialization responsibilities.

✔ Analyze Financial Deal Terms
Review available data on upfront payments, milestone payments, and royalty structures to benchmark the financial value of comparable deals.

✔ Access Real Contract Documents
Where available, the report links directly to SEC-filed agreements, allowing you to review the detailed contractual terms behind major collaboration deals.

✔ Identify the Most Active Collaboration Dealmakers
See which pharmaceutical and biotechnology companies are leading collaboration activity and analyze their partnership strategies.

✔ Track Market Trends in Collaboration Partnerships
Analyze dealmaking activity across companies, therapeutic areas, and technology types to understand how collaboration strategies are evolving.

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in collaboration dealmaking

2.1. Introduction

2.2. Definition of collaboration deal

2.3. Trends in collaboration deals since 2020

2.3.1. Collaboration dealmaking by year

2.3.2. Collaboration dealmaking by phase of development

2.3.3. Collaboration dealmaking by industry sector

2.3.4. Collaboration dealmaking by therapy area

2.3.5. Collaboration dealmaking by technology type

2.3.6. Collaboration dealmaking by most active company

2.4. Reasons for entering into collaboration partnering deals

2.5. The future of collaboration deals

 

Chapter 3 – Overview of collaboration deal structure

3.1. Introduction

3.2. Collaboration agreement structure

 

Chapter 4 – Leading collaboration deals

4.1. Introduction

4.2. Top collaboration deals by value

 

Chapter 5 – Top 25 most active collaboration dealmakers

5.1. Introduction

5.2. Top 25 most active collaboration dealmakers

 

Chapter 6 – Collaboration deals including contracts directory

6.1. Introduction

6.2. Collaboration deals with contracts

 

Deal directory

Deal directory – collaboration dealmaking by companies A-Z

Deal directory – collaboration dealmaking by therapy area

Deal directory – collaboration dealmaking by technology type

 

About Biopharma Research Ltd

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

TABLE OF FIGURES

Figure 1: Definition of collaboration deals

Figure 2: Trends in collaboration deal announcements, 2020-2026

Figure 3: Collaboration deals signed at each phase of development

Figure 4: Collaboration deals by industry sector

Figure 5: Collaboration deals by therapy area

Figure 6: Collaboration deals by technology type

Figure 7: Top 25 most active collaboration dealmakers

Figure 8: Top collaboration deals by value

Figure 9: Most active collaboration dealmakers

Pricing options

• $4,995: single-user (encrypted file - one user/device)
• $6,995: multi-user (encrypted file - up to 5 users/devices)
• $8,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is a division of Biopharma Research Ltd based in County Durham, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

3D Medicines, 3T Biosciences, 4B Technologies, 4C Biomed, 4D Pharma, 4P-Pharma, 7 Hills Pharma, 9 Meters Biopharma, 23andMe, 48Hour Discovery, 111, A*STAR Singapore Immunology Network, A2 Biotherapeutics, Aachen University, Abbisko Therapeutics, Abbott Laboratories, Abbvie, AbCellera Biologics, Abdul Latif Jameel Health, Abilita Therapeutics, ABL Bio, AbSci, AbTherx, ACADIA Pharmaceuticals, AC Bioscience, Accent Therapeutics, Accenture, Access to Comprehensive Genomic Profiling Coalition, ACEA Therapeutics, Acepodia, Acerand Therapeutics, Acerta Pharma, Acer Therapeutics, Ache, Actelion, Actinium Pharmaceuticals, Actuate Therapeutics, Acumen Analytics, Acumen Pharmaceuticals, Adagene, Adapsyn Bioscience, Adaptimmune, Adaptive Biotechnologies, Adaptive Phage Therapeutics, Addex Therapeutics, Adimab, ADMA Biologics, Adrestia, Advancell, Aelis Pharma, Aequus Pharmaceuticals, Aerami Therapeutics, Aerie Pharmaceuticals, AESOP Technology, Aethon Therapeutics, AffaMed Therapeutics, Affimed Therapeutics, Affinia Therapeutics, AffyXell Therapeutics, Agepha Pharma, AgonOx, AIBody, AiCuris, Aignostics, AIkido Pharma, AIon Labs, Aitia, Ajinomoto, Akeso Biopharma, Akili Interactive Labs, Akoya Biosciences, AKSO Biopharmaceutical, Alchemab, Alchemab Therapeutics, Alcyone Therapeutics, Alector, Alectos Therapeutics, Alessa Therapeutics, Alexion Pharmaceuticals, Alex Therapeutics, Alex’s Lemonade Stand Foundation, Algen Biotechnologies, Aligos Therapeutics, AliveCor, ALK-Abello, Alliance for Regenerative Medicine, Allogene Therapeutics, Alloplex Biotherapeutics, Alloy Therapeutics, Allscripts, AllStripes, Allumiqs, Almirall, Alnylam Pharmaceuticals, Alphageneron Pharmaceuticals, Alphamab Biopharmaceuticals, Alpha Tau Medical, Alpine Immune Sciences, Alveo Technologies, Alvogen, ALX Oncology, Alzheimer's Drug Discovery Foundation, Amathus Therapeutics, Amazon Web Services, Ambiopharm, Ambrx, American College of Cardiology, American Society of Gene and Cell Therapy, Amgen, Amicus Therapeutics, Amneal Pharmaceuticals, Amolyt Pharma, Amoy Diagnostics, Amphilix, Amphista Therapeutics, AMRA Medical, Amytrx Therapeutics, AN2 Therapeutics, Anagenex, AnchorDx, Angelini Pharma, Anima Biotech, Anixa Biosciences, Anji Pharma, Anokion, Anpac Bio-Medical Science, Antengene, Antibe Therapeutics, Anumana, Apellis Pharmaceuticals, Apollomics, Apollo Therapeutics, Appia Bio, Appili Therapeutics, Applied BioMath, Aprecia Pharmaceuticals, Apricity Health, APST Research, Aptorum Group, Aqemia, Aqilion, Aquinnah Pharmaceuticals, Araris Biotech, Aravive Biologics, Arbor Biotechnologies, ArcherDX, Arctic Vision, Arcus Biosciences, Arcutis Biotherapeutics, Arecor, Arena Pharmaceuticals, Ares Genetics, Argenta, Argobio, Ariceum Therapeutics, Aro Biotherapeutics, Arrakis Therapeutics, Arrowhead Pharmaceuticals, Arsenal Biosciences, ArtemiLife, Artios Pharma, Artisan Bio, Artiva Biotherapeutics, Arvinas, Arzeda, Asahi Kasei, Asan Medical Center, Ascentage Pharma, Ascidian Therapeutics, Ashvattha Therapeutics, Asieris Pharmaceuticals, Asklepios Biopharmaceutical, Aspect Biosystems, AssayQuant Technologies, Assembly Biosciences, Astellas Pharma, Astellas Pharma US, Astellas Venture Management, Astex Pharmaceuticals, AstraZeneca, ATAI Life Sciences, Atalanta Therapeutics, Atara Biotherapeutics, Atea Pharmaceuticals, Athebio, Atomwise, Atreca, ATUM, aTyr Pharma, AUM Biosciences, Auransa, Aurena Laboratories, Aurigene Discovery Technologies, Aurinia Pharmaceuticals, Autifony Therapeutics, Autigen, Avacta, Avicanna, Avidity Biosciences, Aviko Radiopharmaceuticals, Axcelead Drug Discovery Partners, Axoltis Pharma, Aytu BioPharma, Aztiq, BAKX Therapeutics, Bascom Palmer Eye Institute, Base4 Biotechnology, Basilea Pharmaceutica, Battelle, Baxter International, Bayer, Baylor College of Medicine, B Braun, BC Cancer Agency, Beacon Discovery, Beactica, Beam Therapeutics, Be Biopharma, Beckley Psytech, Beckman Coulter, BehaVR, Beiersdorf, BeiGene, Beijing Tide Pharmaceutical, Belharra Therapeutics, Belief BioMed, Benchling, BenevolentAI, Berg, BerGenBio, Berkeley Lights, Beroni Group, Beth Israel Deaconess Medical Center, Better Therapeutics, Bicycle Therapeutics, Bielefeld University, BigHat Biosciences, Bill and Melinda Gates Foundation, BillionToOne, Bio-Sourcing, BioAge Labs, BioArctic AB, biOasis Technologies, Biocartis, Biocytogen, Bioforum, Biogen, BioGeometry, Biohaven Pharmaceuticals, BIOHM Health Inc, BioLabs, BioLight, BiolineRX, BioLinQ, BiologIC Technologies, Biolojic Design, BioMap, BioMarin Pharmaceutical, BioMark Diagnostics, Biomedical Advanced Research and Development Authority, BioMed X Innovation Center, Biomica, BiomX, BiondVax, Bioniz Therapeutics, BioNova Pharmaceuticals, BioNTech, Biopharmaceutical Research Company, BioPharma Plasma, Bio Products Laboratory, Biora Therapeutics, Biorchestra, BioSymetrics, Biotest, BioTheryX, Biotheus, Biotools, BioVersys, Blacksmith Medicines, Blackstone, Bliss Biopharmaceutical, Blueprint Medicines, BlueRock Therapeutics, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Bophelo Bioscience & Wellness, BostonGene, Bota Bio, BPL Medical Technologies, Brainomix, Brain Research Through Advancing Innovative NeurotechnologiesInitiative, BridgeBio Pharma, Bridge Biotherapeutics, BridGene Biosciences, Brigham and Women's Hospital, BrightInsight, Bright Peak Therapeutics, Brightseed, Bristol-Myers Squibb, Broad Institute, Bruno Farmaceutici, Burning Rock, BYOMass, Byondis, C4 Therapeutics, Calcimedica, Calidi Biotherapeutics, California Institute for Biomedical Research, CAMP4 Therapeutics, Canadian Neuromuscular Disease Registry, Canary Speech, CANbridge Pharmaceuticals, CancerCare, Cannabix Technologies, Capsida Biotherapeutics, Captor Therapeutics, Cara Care, Caraway Therapeutics, Cardiff Oncology, Cardiff University, Care Access Research, Caribou Biosciences, Caris Life Sciences, Carisma Therapeutics, Caristo Diagnostics, Carmine Therapeutics, Cartography Biosciences, Case Western Reserve University, Casma Therapeutics, Catalent, CB Therapeutics, CDR-Life, Cedars-Sinai Medical Center, Celanese, Celcuity, Celdara Medical, Celeri Health, CelerisTx, Celgene, Cellares, Cellarity, Cell Cure Neurosciences, Cellectis, Cellenkos, CELLINK, Cell Mogrify, CellOrigin Biotech, Cellular Biomedicine, Celmatix, Celsius Therapeutics, Celularity, Cend Therapeutics, Centers for Disease Control and Prevention, Centessa Pharmaceuticals, Centre for Addiction and Mental Health, Centre for Commercialization of Regenerative Medicine (CCRM), Centre Leon Berard, Century Therapeutics, Cerevance, Cerevel Therapeutics, Charcot-Marie-Tooth Association, Charles River Laboratories, CHARM Therapeutics, Chi-Med, Chiesi Farmaceutici, China Resources Pharmaceutical Commercial Group International Trading, Chinese Academy of Sciences, Chinook Therapeutics, Cholesgen, Chongqing Yao Pharmaceutical, Chronolife, Chugai Pharmaceutical, Cidara Therapeutics, Ciitizen, Cimeio Therapeutics, Cipla, Circle Pharma, Cirqle Biomedical, City Therapeutics, Civica Rx, CJ CheilJedang, Clarity Pharmaceuticals, Clear Creek Bio, Clearmind Medicine, ClearNote Health, Clene Nanomedicine, Cleveland Clinic, Click Therapeutics, Climate Amplified Disease and Epidemics, Clinica Universidad Navarra, Clinton Health Access Initiative, Clover Biopharmaceuticals, CMG Pharmaceutical, CMS Aesthetics, CNAO Foundation, CND Life Sciences, Coala Life, Coalition for Epidemic Preparedness Innovations, Code Biotherapeutics, Code Ocean, Codex DNA, Codexis, Cognito Therapeutics, Cognizant, Colgate Palmolive, Columbia University, Complix, ConcertAI, Concr, Confo Therapeutics, Congruence Therapeutics, Contera Pharma, Context Therapeutics, Coriolis Pharma Research, COTA, Covant Therapeutics, Covar Pharmaceuticals, Coya Therapeutics, Creyon Bio, Croda, CR Pharma, CSL, CSL Behring, CSPC Pharmaceutical Group, CStone Pharmaceuticals, Cue Biopharma, Cullgen, Cullinan Oncology, Culture Biosciences, Curacle, Curadev Pharma, Curadh MTR, Curadigm, Cure Duchenne, Cure Genetics, CURE Pharmaceutical, Curetis, CureVac, Cyclacel Pharmaceuticals, Cyclenium Pharma, Cyclica, CymaBay Therapeutics, Cytocom, CytoMed Therapeutics, CytomX Therapeutics, Cytoo, CytoReason, D-Wave Quantum, Daewoong Pharmaceutical, Daiichi Sankyo, Dalriada Drug Discovery, Dana-Farber Cancer Institute, Danish Cancer Society Research Center, DarioHealth, Datos Health, Dawn Health, Day One Biopharmaceuticals, DayTwo, Debiopharm, Decibel Therapeutics, deCODE Genetics, Decoy Therapeutics, Deerfield Management, Defence Therapeutics, DelSiTech, Delta 4, Denali Therapeutics, Department of Health - Abu Dhabi, Depixus, Dewpoint Therapeutics, Diabeloop, Diamond Light Source, DIAN Diagnostics, Diatech Pharmacogenetics, Dicerna Pharmaceuticals, Digital Medicine Society, DiNAQOR, Disability Solutions, Diverse Biotech, Diversigen, DNX Biopharmaceuticals, doc.ai, DoctorsOne Healthcare Systems, Dong-A ST, Door Pharmaceuticals, DotBio, DoubleRainbow Biosciences, Dr. Denese SkinScience, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dragonfly Therapeutics, Dragon Sail Pharmaceutical, Dren Bio, Drugs for Neglected Diseases Initiative, Duke Clinical Research Institute (DCRI), Duke University, Dunad Therapeutics, Dyadic International, Dynacure, Dynavax Technologies, Dyno Therapeutics, Eagle Genomics, Earendil Labs, Echosens, Editas Medicine, eFFECTOR Therapeutics, Eikon Therapeutics, Eisai, Eisai Inc, Eko, Elaaj Bio, Eledon Pharmaceuticals, Elegen, Elektrofi, Elevation Oncology, Eleven Biotherapeutics, Elicio Therapeutics, Eligo Bioscience, Eli Lilly, Elix, Elpis Biopharmaceuticals, Elpiscience, Elsevier, Elsie Biotechnologies, Embark Biotech, Emergent BioSolutions, Emmaus Life Sciences, Emory University, Empatica, Empirico, Enable Injections, Enamine, Enara Bio, Encoded Therapeutics, Enesi Pharma, Engitix, Ensoma, Enterome Bioscience, Entos Pharmaceuticals, Entrada Therapeutics, Envisagenics, Enzychem Lifesciences, EpicentRx, Epilepsy Foundation (EF), EpiPharma, Epitopea, Epivax, EQRx, Equillium, Eracal Therapeutics, Erasmus University Medical Center, ESSA Pharma, Essen University Hospital, EtectRx, eTheRNA immunotherapies, ETH Zurich, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eurofins Discovery, European Molecular Biology Laboratory, EVA Pharma, Evelo Biosciences, Everads Therapy, EverInsight Therapeutics, Eversana, Evidation Health, Evinova, Evogene, Evolve BioSystems, EVOQ Therapeutics, Evotec, Evox Therapeutics, Evozyne, EVQLV, ExCEEd Orphan, Exelixis, Exicure, Exonate, Experic, Experimental Drug Development Centre, Exscientia, Eyenovia, EyePoint Pharmaceuticals, F-Star Therapeutics, F4 Pharma, Facio Therapies, Fate Therapeutics, Fauna Bio, Felix Biotechnology, Ferring Pharmaceuticals, Filament Health, FivepHusion, Flagship Biosciences, Flagship Pioneering, Flare Therapeutics, Flatiron Health, Foghorn Therapeutics, Food and Drug Administration (FDA), Forge Therapeutics, Formosa Pharmaceuticals, Forty Seven, Fosun Pharmaceutical, Foundation Medicine, Fox Chase Cancer Center, Fraunhofer Institute for Molecular Ecology (IME), FreeMind Group, Freenome, Fresenius Kabi Pharmaceuticals, Frontier Medicines, Fujifilm, FUJIFILM Cellular Dynamics, Fujirebio Diagnostics, Fulcrum Therapeutics, Fulgent Pharma, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Fusion Pharmaceuticals, G1 Therapeutics, G42 Healthcare, Gain Therapeutics, Galapagos, Galmed Pharmaceuticals, Gan & Lee, GC Biopharma, GC Pharma, GE Healthcare, Geisinger Health System, GEMMA Biotherapeutics, GeneCode, Genentech, General Proximity, Generate Biomedicines, Generian Pharmaceuticals, Geneseeq, Genesis Therapeutics, Genethon, Genetic Leap, GeNeuro, Genevant Sciences, Genfit, GenFleet Therapeutics, Genialis, Genmab, Genocea Biosciences, Genome and Company, Genome Biologics, GentiBio, Genuity Science, Genzyme, German Heart Centre Berlin, Gero, Gerresheimer, GI Innovation, Gilead Sciences, Gilgamesh Pharmaceuticals, Ginkgo BioWorks, Givaudan, Glenmark Pharmaceuticals, Global Antibiotic Research and Development Partnership, Global Response Aid, Global Virus Network, Glooko, GlycoMimetics, GlycoNet, Glysious, GNS Healthcare, GO2 Foundation for Lung Cancer, Goethe University Frankfurt, GoodRx, Google, Gordian Biotechnology, Gossamer Bio, GO Therapeutics, GPCR Therapeutics, Grail, Graviton Bioscience, Greenstone Biosciences, Grifols, Gritstone Bio, Grunenthal, GSK, GSK Consumer Healthcare, Guangzhou Xiangxue Pharmaceutical, Guardant Health, Guerbet, Hadassah Medical Center, Hainan Sihuan Pharmaceutical, Halia Therapeutics, HALO Precision Diagnostics, Halozyme Therapeutics, HanAll Pharmaceuticals, HanchorBio, Handok Pharmaceuticals, Hangzhou Chance Pharmaceuticals, Hangzhou Zhongmei Huadong Pharmaceutical, Hansa Biopharma, Happify Health, Harbour Biomed, Harvard Medical School, Harvard University, Haystack Oncology, Healion Bio, Healis Therapeutics, HealthSnap, Heartseed, HebeCell, Hebrew University of Jerusalem, Helsinn Healthcare, Helsinn Therapeutics, HemoShear, Hengrui Therapeutics, Henlius Biotech, Hetero Labs, HiFiBio, HighRes Biosolutions, Hillstream BioPharma, HitGen, HK inno.N, Hoffmann La Roche, Holmusk, Holobeam Technologies, Holobiome, Hong Kong Science and Technology Parks, Hookipa Pharma, Horizon Therapeutics, Hospital for Special Surgery, Hoth Therapeutics, HotSpot Therapeutics, Hox Therapeutics, Huadong Medicine, Huma, Hume Supernatural, Hummingbird Bioscience, Hurdle, I-mab, i2O Therapeutics, IACTA Pharmaceuticals, Iambic Therapeutics, IASO Biotherapeutics, IBA, Icagen, Icahn School of Medicine at Mount Sinai, Ichnos Sciences, ICL, Iconovo, IDEAYA Biosciences, Idorsia, iGenomix, IGM Biosciences, IgniteData, Iktos, Ildong Pharmaceutical, Illumina, ImaginAb, Imagine Pharmaceuticals, IMBdx, Imcyse, IMIDomics, Immatics Biotechnologies, Immunai, Immuneering, Immune Therapeutics, ImmunoForge, ImmunoGen, Immunome, Immuron, Immusoft, Immutep, ImmVira, IMPACT Therapeutics, Imperial College London, Imugene, INBRAIN Neuroelectronics, InCarda Therapeutics, Incyte, Indiana University, Indivior, Indivumed, InduPro Therapeutics, Infex Therapeutics, Inivata, INNERVIA Bioelectronics, InnoCentive, Innodem Neurosciences, Innoplexus, Innovare, Innovative Medicines Initiative (IMI), Innovent Biologics, Insilico Medicine, InSilicoTrials, Insitro, InSphero, Inspirna, Institute for Research in Immunology and Cancer – Commercialization of Research, Institute for Systems Biology, Institute of Cancer Research, Institut Gustave Roussy, Institut Kanser Negara, Intec Pharma, Integral Molecular, Interaxon, International Diabetes Federation (IDF), IntuitiveX, InveniAI, Invenio Imaging, Invenra, Inventia Life Science, Inventiva, Invetx, InVirtuoLabs, Invitae, InxMed, Ionis Pharmaceuticals, ipCapital Group, Ipsen, IQVIA, ISD Immunotech, Isomorphic Labs, Italian Association for the Study of Pancreas, Iterative Scopes, Iterion Therapeutics, ITM Isotopen Technologien, Jackson Laboratory, Jacobio Pharmaceuticals, Jaguar Health, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Janssen Therapeutics, Janux Therapeutics, Japan Tobacco, Javelin Biotech, Jazz Pharmaceuticals, JCR Pharmaceuticals, Jenner Institute, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Medicine, Jiangsu Hengrui Pharmaceuticals, Jiangsu NHWA Pharmaceutical, Jnana Therapeutics, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Consumer Companies, Johnson & Johnson Innovation, Johnson & Johnson Vision, Jubilant Biosys, Jubilant Radiopharma, Junshi Biosciences, Juvena Therapeutics, Juvenile Diabetes Research Foundation, Kadimastem, Kadmon Pharmaceuticals, Kainos Medicines, Kaken Pharmaceutical, Kaleido Biosciences, KaliVir Immunotherapeutics, Kamada, KangaBio, Karkinos Healthcare, Karolinska Institute, Karuna Therapeutics, Karyopharm Therapeutics, Kazia Therapeutics, Kedrion Biopharma, Kelai Pharmaceuticals, Kelonia Therapeutics, Kelun-Biotech Biopharmaceutical, Kenya Medical Research Institute, Kettering Health, KeyBioScience, Kiadis Pharma, Kings College London, Kiniksa Pharmaceuticals, Kinnate Biopharma, Kira Pharmaceuticals, Kitanihon Pharmaceutical, Kit Check, Kite Pharma, Kling Biotherapeutics, Kobe University, Kodiak Sciences, Komodo Health, Koneksa Health, Korea Institute of Radiological and Medical Sciences, Koru Medical Systems, Kowa, Kronos Bio, KSQ Therapeutics, KTH Royal Institute of Technology, Kumquat Biosciences, Kura Oncology, Kvantify, Kymera Therapeutics, Kyorin Pharmaceutical, Kyowa Hakko Kirin, Kyverna Therapeutics, L'Oreal, LabCentral, Laboratoires Thea, Laboratorios Farmaceuticos Rovi, Lacerta Therapeutics, Landos Biopharma, Langara College, LaNova Medicines, Lantern Pharma, Lantheus Holding, Lantheus Medical Imaging, Latvian Institute of Organic Synthesis, Launch Therapeutics, Laurus Labs, Lavie Bio, Lead Pharma, Lee Moffitt Cancer Center, LegoChem Biosciences, Leiden University, Leidos, LEO Pharma, Les Laboratoires Servier, Leveragen, LEXEO Therapeutics, Lexicon Pharmaceuticals, LFB Biotechnologies, LFB Group, LG Chem, LianBio, LiberoThera, Lieber Institute, Liechti Lab, LifeArc, Life Edit Therapeutics, LifeMine Therapeutics, Life Raft Group, LifeSci Advisors, Ligand Pharmaceuticals, Light Chain Bioscience, Lightpoint Medical, Lineage Cell Therapeutics, Lipidor, Lipigon Pharmaceuticals, Lisata Therapeutics, LogicBio Therapeutics, Lonza, Lotus Pharmaceuticals, Loulou Foundation, Loxo Oncology, Lumoptik, Lundbeck, Lundquist Institute, Lung Biotechnology, Lung Cancer Foundation of America, Lung Cancer Initiative, Lung Cancer Research Foundation, LUNGevity Foundation, Lunit, Luxna Biotech, Lycia Therapeutics, Lyell Immunopharma, LyGenesis, Lygos, Lynk Pharmaceuticals, Lysando, M42, Macomics, Macrogenics, Magnet Biomedicine, MAIA Biotechnology, Mammoth Biosciences, Manny Pacquiao Foundation, Marengo Therapeutics, Marinus Pharmaceuticals, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, MassBio, Mass General Brigham, Matinas Biopharma, Matrix Medical Network, Max-Planck, Max Biopharma, Maxcyte, Mayo Clinic, Maze Therapeutics, MC2 Therapeutics, McGill University, McKesson, McQuade Center for Strategic Research and Development, MD Anderson Cancer Center, MDimune, Medac, Medial EarlySign, Medicago, Medichem International, MEDiC Life Sciences, MediGene, MediLink Therapeutics, Medison Pharma, Medolife Rx, Medomie Pharma, MedPharm, Medtronic, Meharry Medical College, Meiji Seika, Memorial Sloan Kettering Cancer Center, Memo Therapeutics, Menarini, Menicon, Merck and Co, Merck Animal Health, Merck KGaA, Merck Sharpe & Dohme, Mereo BioPharma, Mersana Therapeutics, Merus, Mesoblast, Mestag Therapeutics, Metaba, Metabolon, Metaphore Biotechnologies, Metrion Biosciences, MetVital, Microbiome Therapeutics Innovation Group, Microsoft, MILA International, MilliporeSigma, Mimetas, MiNA Therapeutics, Mind Medicine, MindRank AI, Mindset Pharma, Minovia Therapeutics, Mirati Therapeutics, miRecule, Mirimus, Miromatrix Medical, Mirum Pharmaceuticals, Mitobridge, Mitsubishi Tanabe Pharma, Mitsui, Modag, Moderna, ModeX Therapeutics, Molecular Partners, Molecular Templates, MOMA Therapeutics, Monash University, Monopar Therapeutics, Monte Rosa Therapeutics, Morningside Ventures, Morphic Therapeutic, MorphoSys, Mosanna Therapeutics, MSD, Multimmune, MyBiotics Pharma, MyMD Pharmaceuticals, MyoKardia, Myotonic Dystrophy Clinical Research Network, Myovant Sciences, NAMUH, Nanoform, NaNotics, NanoVation Therapeutics, Nanyang Technological University, Nashville Biosciences, NATA, Natera, National Cancer Center, National Comprehensive Cancer Network (NCCN), National Eye Institute, National Heart, Lung and Blood Institute, National Human Genome Research Institute, National Institute for Innovation in Manufacturing Biopharmaceuticals, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal Diseases, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Infectious Diseases, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Pharmaceutical Education and Research, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, National Organization for Rare Disorders, National Resilience, Natural Sciences and Engineering Research Council of Canada, NatureWorks, Navigo Proteins, Navrogen, nCage Therapeutics, Nektar Therapeutics, Nemysis, Neochromosome, NeoImmuneTech, Neokidney, Neolaia Bio, Neomorph, NeoPhore, Neotope, NervGen Pharma, Nerviano Medical Sciences, Nestle Health Science, NETRIS Pharma, Neumora Therapeutics, Neuramedy, Neurimmune Therapeutics, NeuroBiogen, NeuroBo Pharmaceuticals, Neurocrine Biosciences, Neurodon, Neurogene, NeuroLucent, NeuroSense Therapeutics, Neutron Therapeutics, Newsoara Biopharma, New York Presbyterian/Columbia, Nexelis, Nextage Therapeutics, NextRNA Therapeutics, Nicox, NiKang Therapeutics, Nimble Therapeutics, Nimbus Therapeutics, NIMIUM Therapeutics, Niowave, Nippon Shinyaku, NKGen Biotech, NKMax America, NLS Pharmaceutics, Noetik, Nona Biosciences, Northeastern University, NorthStar Medical Radioisotopes, Novadiscovery, Novartis, Novartis Institutes for BioMedical Research, Novavax, Novel Biologics, Novelty Nobility, Novome Biotechnologies, Novo Nordisk, NRx Pharmaceuticals, Nucleai, Nuclidium, Numab, NuMedii, Nuntius Therapeutics, Nurix Therapeutics, Nusano, NVDIA Corporation, Nykode Therapeutics, NYtor, NYU Langone Medical Center, Oblique Therapeutics, Obsidian Therapeutics, Ocean Spray Cranberries, Ochre Bio, Octapharma, Ocular Therapeutics, ODx, Odyssey Therapeutics, OG DNA Genetics, Okava Pharmaceuticals, Olema Oncology, OliPass, OliX Pharmaceuticals, Omega Laboratories, Omega Therapeutics, Omniose, Oncidium Foundation, OncoArendi Therapeutics, Oncode Institute, Oncodesign, Oncoheroes Biosciences, Oncologie, Oncolytics Biotech, OncoNano Medicine, Oncorus, Oncternal Therapeutics, OneOncology, OneThree Biotech, oNKo-innate, Ono Pharmaceutical, Ontario Institute for Cancer Research, Ontochem, Onward Therapeutics, OpenAI, Open Book Extracts, OpGen, Opsis Therapeutics, Optellum, Optimi Health, Orano Med, Orbis Medicines, Orbit Discovery, Oregon Health Sciences University, Oregon Therapeutics, Orexia Therapeutics, Organon, ORIC Pharmaceuticals, Origami Therapeutics, OrigiMed, Orion, Orionis Biosciences, Orna Therapeutics, Oscotec, Osivax, OTR Therapeutics, Otsuka, Ottimo Pharma, Ovid Therapeutics, Owkin, Oxford BioTherapeutics, Oyster Point Pharma, Ozette Technologies, Pacific Pediatric Neuro-Oncology Consortium, PACT Pharma, Paige, Palatin Technologies, Palisade Bio, Palleon Pharmaceuticals, panCELLa, Paradigm, Paraza Pharma, Parkinson's Disease Foundation, Parkinson's UK, Parkinsons Disease Foundation, Partner Therapeutics, Pascal Biosciences, Passage Bio, PathAI, Pathalys Pharma, PaxMedica, PCI Pharma Services, Pearl Bio, PEAR Therapeutics, PECET, Peijia Medical, Peking Union Medical College, Pennsylvania Biotechnology Center, Pepper Bio, PeptiDream, PerkinElmer, Persephone Biosciences, Personal Genome Diagnostics, Personalis, Peter MacCallum Cancer Institute, Pfizer, Pfizer Canada, PGI Drug Discovery, PharmAbcine, PharmaBiome, PharmaEngine, PharmaLogic, PharmaTher, PharmEnable, Pharming Group, Phenomic AI, Philogen, Phio Pharmaceuticals, PhoreMost, PhotonPharma, Photys Therapeutics, Phylloceuticals, PhysIQ, Pieris Pharmaceuticals, Pierre Fabre, Pillar Biosciences, Pioneering Medicines, Plexium, Pluristem Therapeutics, PlusVitech, Pneuma Systems, POINT Biopharma, PointClickCare Technologies, PolarisQB, PoloMar Health, Population Health Partners, Porton Pharma Solutions, Poseida Therapeutics, PostEra, Pragma Bio, Praxis Precision Medicines, Precision BioSciences, PrecisionLife, Predicine, Pregene Biopharma, Prellis Biologics, Pressure BioSciences, Prevail Therapeutics, Primary Peptides, Prime Medicine, PRISM BioLab, ProBioGen, Procyon Technologies, ProEn Therapeutics, ProFound Therapeutics, Progenetics, Progenics Pharmaceuticals, Prokaryotics, Prolytix, Prometheus Biosciences, Promises Innovative Recovery Center, Prophase Labs, ProQR Therapeutics, Protagonist Therapeutics, ProteinQure, Proteros biostructures, Prothena, Proxygen, PsychoGenics, PTC Therapeutics, Pulmatrix, Pulmonary Fibrosis Foundation (PFF), Puma Biotechnology, Purdue University, QED Therapeutics, QIAGEN, Qilu Pharmaceutical, Qinotto, Quanterix, Quantum Leap Health Care Collaborative, Quebec Heart and Lung Institute, Quell Therapeutics, QurAlis, Quris-AI, Ractigen Therapeutics, Radient Technologies, Radionetics Oncology, Radiopharm Theranostics, Rafa Laboratories, Rakuten Medical, Rallybio, Rani Therapeutics, Ratio Therapeutics, RayzeBio, Reckitt Benckiser, Recludix Pharma, Rectify Pharmaceuticals, Recursion, RedHill Biopharma, Redx Pharma, RefleXion Medical, ReForm Biologics, Regeneron Genetics Center, Regeneron Pharmaceuticals, Regenxbio, Regional Cancer Institute of Montpellier, Regor Therapeutics, Relation Therapeutics, Relay Therapeutics, Relief Therapeutics, Remedium Bio, Remix Therapeutics, ReNAgade Therapeutics, Renexxion, RenovoRx, Repare Therapeutics, Repertoire Immune Medicines, Replicate Bioscience, Repurpose.AI, RespireRx Pharmaceuticals, RetinAI Medical, Reverie Labs, reViral, ReviR Therapeutics, ReVision Optics, Revision Skincare, Revitope Oncology, Revive Therapeutics, RevolKa, Revolution Medicines, Revvity, Reyon Pharmaceuticals, Rgenta Therapeutics, RheaVita, Ribometrix, Ridgeback Biotherapeutics, RIKEN Research Institute, Ripple Therapeutics, Rising Pharmaceuticals, Roche, Roche Diagnostics, Rocket Pharmaceuticals, Rohto Pharmaceutical, Roivant Sciences, Rondo Therapeutics, Roswell Biotechnologies, Roswell Park Cancer Institute, Royalty Pharma, RS BioTherapeutics, Rubedo Life Sciences, Rugen Therapeutics, Russian Direct Investment Fund, RVL Pharmaceuticals, Ryerson University, Ryvu Therapeutics, Saama, SAB Biotherapeutics, SAGA Diagnostics, Sage Therapeutics, Salarius Pharmaceuticals, Salipro Biotech, Salk Institute, Samsung Biologics, Samyang Biopharmaceuticals, Sandoz, SanegeneBio, Sangamo Therapeutics, Sanguina, Saniona, Sanofi, Sanofi-Pasteur, Sanquin Blood Supply Foundation, Santen Pharmaceutical, Sanyou Biopharmaceuticals, Saphetor, Sapien Biosciences, Sarah Cannon Research Institute, Sato Pharmaceutical, Savara Pharma, Scenic Biotech, Scholar Rock, Schrodinger, SciBase, SciClone Pharmaceuticals, Science 37, Scilex Holding, SciNeuro Pharmaceuticals, Scipher Medicine, SciSparc, Sciwind Biosciences, Scorpion Therapeutics, Scribe Therapeutics, Scripps Research Institute, Scriptr Global, Seagen, Seamless Therapeutics, Sean M Healey & AMG Center for ALS, Seattle Genetics, Secarna Pharmaceuticals, Second Genome, Sedec Therapeutics, Seed Therapeutics, Seelos Therapeutics, Selagine, SelectImmune Pharma, Sema4, SemaThera, Sengenics, Senju Pharmaceutical, Sensory Cloud, Sentinel Oncology, Septerna, Sequence Bio, Sequential Skin, SeraNovo, Serina Therapeutics, Sermonix Pharmaceutical, Sernova, Serotiny, Serum Institute of India, Servatus Biopharmaceuticals, Shanghai Argo Biopharmaceutical, Shanghai Institute of Materia Medica, Shanghai Medicilon, Shanghai Pharmaceuticals Holdings, Shape Therapeutics, Shasqi, Shattuck Labs, Sheba Medical Center, Shenzhen Institutes of Advanced Technology, Shepherd Therapeutics, Shionogi, Shoreline Biosciences, Sibylla Biotech, Siemens Healthineers, SIGA Technologies, Sigilon Therapeutics, Signet Therapeutics, Silence Therapeutics, Simcere Pharmaceuticals, Simulations Plus, Singapore General Hospital, Singapore Sengkang General Hospital, Singlera Genomics, Singular Genomics Systems, Sino Biopharmaceutical, Sinorda Biomedicine, Sinovac Biotech, Sirenas, Sirion Biotech, Sirnaomics, Sironax, SIRS Therapeutics, Sirtex Medical, SiteOne Therapeutics, Sitryx, SK Biopharmaceuticals, Skyhawk Therapeutics, SmartPharm Therapeutics, Sofie Biosciences, Sohm, Soleno Therapeutics, Solid Biosciences, Sonnet BioTherapeutics, Sonoma BioTherapeutics, Sony, SOPHiA Genetics, Sorrento Therapeutics, Sorse Technology, Sosei, Sosei Heptares, Spanish National Research Council, Spark Therapeutics, Specifica, SpineThera, Spiral Therapeutics, SpringWorks Therapeutics, SRI International, Stanford University, Stanford University School of Medicine, Starpharma, Statera Biopharma, Step Pharma, Stereotaxis, Stevanato, Storm Therapeutics, Strand Life Sciences, Structural Genomics Consortium, Subtle Medical, Sumitomo Chemical Company, Sumitomo Dainippon Pharma, Sumitomo Mitsui Banking Corporation, Sumitomo Pharmaceuticals, Sumitovant Biopharma, Summit Therapeutics, Sunovion Pharmaceuticals, Sun Pharma Advanced Research Company, Sunshine Biopharma, Surrozen, Sutro Biopharma, Suzhou Ribo Life Sciences, Swiss Institute of Bioinformatics (SIB), Swiss Rockets, Syapse, Sygnature Discovery, SylamoreBio, Symvivo, Synbiotech, Syndax Pharmaceuticals, Syneos Health, Syngene International, Synthekine, SyntheX, Sysmex, Sysnav Healthcare, Systimmune, TAE Life Sciences, Tahoe Therapeutics, Taiho, Taisho Pharmaceutical, Takeda Pharmaceutical, Tallac Therapeutics, TALLC, TargetGene Biotechnologies, Tarveda Therapeutics, Tavotek Biotherapeutics, Tavros Therapeutics, Taysha Gene Therapies, Tegmine Therapeutics, Teijin, TeleVet, Telix Pharmaceuticals, Tella, Telomir Pharmaceuticals, Tempest Therapeutics, Tempus, Ten63 Therapeutics, Tenacia Biotechnology, TeneoBio, TenNor Therapeutics, Tentarix Biotherapeutics, Terns Pharmaceuticals, Terray Therapeutics, Terumo Blood and Cell Technologies, Tetra Pharm Technologies, TetraScience, Teva Pharmaceutical Industries, Tevard Biosciences, Texas Biomedical Research Institute, Texas Lung Injury Institute, TFF Pharmaceuticals, The Access to Advanced Health Insitute (AAHI), The International AIDS Vaccine Initiative, The Jackson Laboratory, The New York Stem Cell Foundation, Theralase, TheraPanacea, Therapix Bio, Thermo Fisher Scientific, ThinkingNodeLife, Thoeris, Thorne HealthTech, TiumBio, TONIX Pharmaceuticals, Totus Medicines, Transcenta, TransCode Therapeutics, Transgene, Translate Bio, TransThera, TreeFrog Therapeutics, Treehill Partners, Trevena, Treventis, TRexBio, TrialSpark, Triastek, Trigone Pharma, TriSalus Life Sciences, Trutino Biosciences, TRx Biosciences, TSB Therapeutics, TScan Therapeutics, TTC, TTP Group, Tubulis, Turbine, Turnstone Biologics, Twist Bioscience, Ubie, Ubiquigent, UbiVac, Ubix Therapeutics, UCB, UK Biobank, Ultivue, Ultragenyx Pharmaceuticals, Umoja Biopharma, Unilever, UniQuest, UniQure, United Therapeutics, Universal Display, Universe Pharmaceuticals, University College London, University Gottingen, University Health Network, University Libre of Brussels, University Medical Center Utrecht, University of Alberta, University of Arizona, University of Barcelona, University of British Columbia, University of Calgary, University of California, Davis, University of California, San Diego, University of California Berkeley, University of California Los Angeles, University of California San Francisco, University of Colorado, University of Connecticut, University of Dundee, University of Edinburgh, University of Florida, University of Georgia, University of Health Sciences Antigua, University of Helsinki, University of Maryland School of Medicine, University of Massachusetts Medical School, University of Minnesota, University of Montreal, University of Nebraska, University of North Carolina, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Queensland, University of Saskatchewan, University of South Australia, University of Texas, University of Texas Health SCience Center at San Antonio, University of Texas Health Science Center at Tyler, University of Toronto, University of Tsukuba, University of Washington, Unlearn, Unnatural Products, Unravel Biosciences, UPL, Uppthera, UroGen Pharma, UroViu, US Army Medical Research and Material Command, US Army Medical Research Institute of Infectious Diseases, US Government, US Oncology Research, Usynova Pharmaceuticals, Utrecht University, Vaccibody, Valence Discovery, Vall d’Hebron Research Institute, Valneva, Valo Health, Vanda Pharmaceuticals, Vanderbilt University, Vanguard Scientific Systems, VantAI, Variant Bio, VaxEquity, Vector Institute, Veeva Systems, VenatoRx, Veracyte, Verana Health, Verantos, Veraxa Biotech, Verge Genomics, Verily, VerImmune, Vernalis, Verseau Therapeutics, Vertex Pharmaceuticals, Verve Therapeutics, Vestibular Disorders Association, Vetigenics, ViaNautis Bio, Viatris, Vibliome Therapeutics, Vicore Pharma, Vidscrip, ViGeneron, Vincere Biosciences, Vipergen, Vir Biotechnology, Virginia Tech, Viroclinics Biosciences, Visiopharm, VistaGen Therapeutics, Visus Therapeutics, Vitruvias Therapeutics, Vivani Medical, VivaVision Biotech, Vivera Pharmaceuticals, Vividion Therapeutics, Vivtex, Volastra Therapeutics, Vor Biopharma, Voyager Therapeutics, Vuja De Sciences, WaVe Lifesciences, WAVE Life Sciences, Wayfinder Biosciences, Weatherden, WeComput, Weill Cornell Medical College, Wellcome Trust, Werewolf Therapeutics, West Pharmaceutical Services, WuXi Biologics, Wuxi Shuangliang Biotechnology, Wyss Institute, X-chem, Xcellon Biologics, Xencor, Xenon Pharmaceuticals, XERIS Pharmaceuticals, Xilio Therapeutics, XtalPi, Xyphos Biosciences, Yale School of Medicine, Yale University, YASKAWA Electric, Yingli Pharma, Yissum Research Development, Yiviva, Ypsomed, Yumanity Therapeutics, ZAI Laboratory, Zealand Pharma, ZebiAI Therapeutics, Zedira, Zelira Therapeutics, Zenas BioPharma, Zentalis Pharmaceuticals, Zerion Pharma, Zifo, Zogenix, Zonsen PepLib Biotech, ZYUS Life Sciences

About Current Partnering

A definitive, evidence-based approach to dealmaking intelligence

Current Partnering is the industry-leading provider of pharmaceutical and biotech dealmaking intelligence, delivering a clear, structured, and evidence-based view of how partnerships are designed, negotiated, and executed in practice.

Our reports combine comprehensive deal coverage, structured data analysis, and contract-level insight, enabling a deeper understanding of how financial terms, rights, and responsibilities are defined across real-world transactions.

All reports are updated every six months, ensuring users have access to the latest deal activity, trends, and market developments.

---

Our methodology

Built on a continuously updated proprietary database

All analysis is underpinned by Current Agreements, our proprietary deals and alliances database which is updated daily by our analysts as new transactions are announced globally.

Deal records are continuously reviewed and enriched as additional information becomes available, ensuring accuracy, completeness, and relevance.

---

Comprehensive and verifiable data sourcing

Deal data is sourced from publicly available industry disclosures, including:

• Company press releases and announcements
• SEC filings and equivalent regulatory disclosures
• Company and investor presentations
• Conference materials and company websites

All sources are captured and referenced, enabling full transparency and user verification.

---

Broad coverage across deal types and structures

Current Partnering provides comprehensive coverage across a wide range of deal types, including but not limited to:

• Licensing and co-development
• Research and collaborative R&D
• Manufacturing, supply, and distribution
• Commercialisation and co-promotion
• Equity investments, joint ventures, and asset transactions
• Options, royalties, and financing agreements

This breadth ensures a complete view of how partnerships are structured across the life sciences sector.

---

Structured, standardised analysis

Every deal is analysed using a consistent framework, capturing (where disclosed):

• Financial terms — including upfront payments, milestones, and royalties
• Rights allocation — development, manufacturing, and commercialization responsibilities
• Deal structure — exclusivity, territorial scope, and agreement type
• Contractual provisions — clauses defining risk, control, and value-sharing

Each deal record is fully categorised, including data fields such as:

• Therapy area and technology type
• Stage of development
• Asset type and deal components
• Geographic scope and exclusivity
• Source documentation, including press releases and SEC filings

---

Financial normalisation for comparability

All financial values are standardised to USD using the exchange rate at the time of deal announcement, enabling consistent comparison of deal terms across geographies.

---

Contract-level insight

Where available, reports include direct access to underlying agreement documents, providing visibility into how deals are constructed in practice.

This enables users to understand:

• How financial mechanisms are defined and triggered
• How responsibilities are operationalised between parties
• How flexibility, risk, and control are allocated within agreements

---

Designed for real-world application

Current Partnering reports are built to support business-critical decision-making across the life sciences ecosystem, including:

• Pharmaceutical and biotech companies — benchmarking deals, structuring transactions, and supporting licensing strategy
• Investment firms and venture capital — assessing deal benchmarks, valuation expectations, and partner behaviour
• Advisory, legal, and consulting firms — supporting client engagements with real-world precedent and contract-level insight

Common use cases include:

• Benchmarking comparable transactions
• Supporting valuation and deal structuring
• Preparing for negotiations
• Evaluating potential partners
• Informing internal strategy with real-world evidence

---

A trusted industry reference

With a long track record in the sector, Current Partnering is relied upon by leading pharmaceutical companies, emerging biotechs, investors, and advisory firms as a trusted source of dealmaking intelligence.

By combining proprietary data, rigorous methodology, and contract-level insight, our reports provide a reliable and authoritative foundation for understanding how deals are structured, negotiated, and valued.